603087 Gan & Lee Pharmaceuticals.

Watchlist

45.77
+0.24+0.53%

Market Closed Dec 20 15:00 CST

27.51BMarket Cap47.38P/E (TTM)

Gan & Lee Pharmaceuticals. Key Stats

According to the latest financial report of Gan & Lee Pharmaceuticals., the latest earnings per share (TTM) for the company is 0.85. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Gan & Lee Pharmaceuticals.'s latest financial report to see how much their book value per share (BVPS) is currently at 18.65.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Gan & Lee Pharmaceuticals. shows that the company's current ratio is 8.04, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Gan & Lee Pharmaceuticals., the quick ratio is 6.77, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Gan & Lee Pharmaceuticals.? The latest ROE figure is 4.62%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Gan & Lee Pharmaceuticals., the total asset return on investment (ROA) is 4.24%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Gan & Lee Pharmaceuticals.'s latest financial report to see how their gross margin is doing - currently at 75.36%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Gan & Lee Pharmaceuticals., the net profit margin is 22.60%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers

Symbol Price % Chg

Zhejiang Lanyu Digital Technology